Ciclopirox topical - Valeant Pharmaceuticals

Drug Profile

Ciclopirox topical - Valeant Pharmaceuticals

Alternative Names: 12% Ciclopirox lacquer - Valeant Pharmaceuticals; 8% Ciclopirox lacquer - Valeant Pharmaceuticals; Ciclopirox nail lacquer - Valeant Pharmaceuticals; DL 6045; Penlac; Penlac Nail Lacquer

Latest Information Update: 20 Dec 2011

Price : $50

At a glance

  • Originator Dermik Laboratories
  • Developer Valeant Pharmaceuticals International
  • Class Antifungals; Pyridones; Small molecules
  • Mechanism of Action Mitosis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Onychomycosis

Most Recent Events

  • 16 Dec 2011 Dermik Laboratories has been acquired by Valeant Pharmaceuticals International
  • 27 Aug 2004 Aventis has merged with Sanofi-Synthélabo to form sanofi-aventis
  • 26 Feb 2004 Data presented at the 62nd Annual Meeting of the American Academy of Dermatology (AAD-2004) have been added to the Mycoses therapeutic trials section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top